Page 3 - Stevene Nissen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stevene nissen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stevene Nissen Today - Breaking & Trending Today

Statin-intolerant patients receiving alternatives

Statins are one of the most prescribed drugs in the country. But what happens if you are statin-intolerant? It turns out, there’s other help for your heart. ....

United States , Stevene Nissen , Heart Vascular Thoracic Institute At Cleveland Clinic , Ivanhoe Newswire , Chief Academic Officer , Heart Vascular , Thoracic Institute , Cleveland Clinic , Doctor Nissen , Plan B ,

Plan B for Statin-Intolerant Patients

Plan B for Statin-Intolerant Patients
walb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from walb.com Daily Mail and Mail on Sunday newspapers.

United States , Stevene Nissen , Heart Vascular Thoracic Institute At Cleveland Clinic , Ivanhoe Newswire , Chief Academic Officer , Heart Vascular , Thoracic Institute , Cleveland Clinic , Doctor Nissen ,

Two new studies point to the promise of gene therapy for high cholesterol

Two new studies point to the promise of gene therapy for high cholesterol
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United States , New York , Andrew Bellinger , Stevene Nissen , Sahil Parikh , Steve Nissen , Hugh Cassiere , Sekar Kathiresan , American Heart Association , Vascular Thoracic Institute , Shore University Hospital , Drug Administration , Us Centers For Disease , Journal Of The American Medical Association , Columbia University Irving Medical Center , Northwell Cardiovascular Institute , South Shore University Hospital , Boston Based Verve Therapeutics , Massachusetts General Hospital , New York City , Thoracic Institute , Cleveland Clinic , American Medical , South Asian , Extended Duration Short Interfering , Disease Control ,

Sustained Reductions in Lp(a) Achieved With Novel siRNA Drug

In an early phase multicenter study, reductions in lipoprotein(a) to undetectable levels were achieved with a small interfering RNA therapeutic, lepodisiran. ....

United States , Los Angeles , Michellel Odonoghue , Stevene Nissen , Donald Lloyd Jones , Karol Watson , Journal Of The American Medical Association , Department Of Preventive Medicine , Lerner College Of Medicine At Cleveland Clinic , American Heart Association Scientific Sessions , Geffen School Of Medicine , Lerner College , Cleveland Clinic , Strongly Associated With , American Medical , New England Journal , Not Responsive , Preventive Medicine , Northwestern Medicine , Ipid Management , Cv Risk , Cardiovascular Risk , V Risk Factors , Cardiovascular Risk Factors , Cardiovascular Risk Management , Healthcare And Medical Technology ,

Data Show Lepodisiran Was Well Tolerated, Substantially Lowered Lipoprotein (a)

Elevated Lp(a), which was previously untreatable, may become treatable in the near future, according to the study investigator. ....

United States , Eli Lilly , Stevene Nissen , American Heart Association , Arnold Miller Family Heart , Thoracic Institute , Cleveland Clinic , Scientific Sessions ,